| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2007 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 0.644 | 0.615 | 2.8E-27 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
apoptosis inducing factor mitochondria associated 1 | 0.527 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ankyrin 1 | 0.540 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ankyrin 2 | 0.626 | 0.538 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ankyrin repeat domain 1 | 0.628 | 0.692 | 2.6E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
arrestin beta 2 | 0.561 | 0.769 | 0.51 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 | 0.682 | 0.423 | 1.5E-14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2017 | ||||||||
|
ATP synthase F1 subunit delta | 0.674 | 0.500 | 7.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2004 | 2013 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2009 | 2014 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2006 | 2013 |